Pemanfaatan Jamur Armillaria Mellea Sebagai Enzim Fibrinolitik Pendegradasi Fibrin

Yones Guntoro Aji / 202100050006

Caroline Mega Artha / 202100050012

Sumber Referensi

[1] Gifford S, Sarr M, Kamath P. 2015. Treatment of mesenteric venous thrombosis. Di dalam: Oderich GS, editor. Mesenteric vascular disease: current therapy. New York (US): Springer. 

[2] Piazza G, Goldhaber SZ. 2010. Venous thromboembolism and atherothrombosis an integrated approach. Circulation. 121 (19): 2146-2150.

[3] Centers for Disease Control and Prevention. 2022. Venous thromboembolism: impact of blood clots on the United States. United States Department of Health and Human Services. 

[4] Joyce LK, Evelyn RH. 1996. Farmakologi. Jakarta (ID): Penerbit Buku Kedokteran EGC.

[5] Kumar SS, Sabu A. 2019. Fibrinolytic enzymes for thrombolytic therapy. Advances in Experimental Medicine and Biology. 1148: 345-381.

[6] Holden RW. 1990. Plasminogen activators: pharmacology and therapy. Radiology. 174: 993-1001.

[7] Voet D, Voet JG. 1990. Biochemistry. New York (US): Wiley. 

[8] Lee SY, Kim JS, Kim JE, Sapkota K, Shen MH, Kim S, Chun HS, Yoo JC, Choi HS, Kim MK, Kim SJ. 2005. Purification and characterization of fibrinolytic enzyme from cultured mycelia of Armillaria mellea. Protein Expression and Purification. 43: 10-17.